BAX could well have been the partner who pulled out. (‘alia’ joked about this in #msg-29137897.) However, if BAX was in fact the one, I doubt that the heparin problem was their main reason to walk away from an almost-signed ATryn deal.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”